Does Dr. ABDEL KAREEM ABU MALOUH have financial conflicts of interest?

Dr. ABDEL KAREEM ABU MALOUH (MD) has received a total of $89 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $89 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ABDEL KAREEM ABU MALOUH?

According to CMS Open Payments data, Dr. ABDEL KAREEM ABU MALOUH received funding from SHIONOGI ($28), MAYNE PHARMA ($18), and THERATECHNOLOGIES ($17).

Does Dr. ABDEL KAREEM ABU MALOUH receive research grants or speaking fees?

Dr. ABDEL KAREEM ABU MALOUH has received $89 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ABDEL KAREEM ABU MALOUH

MDReal-Time Hydrated

Specialty: Internal Medicine, Infectious Disease

Practice Location: LOUISVILLE, KY 40202

NPI Number: 1396900387

LIFETIME INDUSTRY VALUE

$89

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABU MALOUH is a verified Internal Medicine, Infectious Disease practitioner based in LOUISVILLE, KY.

Between 2021 and 2024, Dr. ABU MALOUH had an overall industry promotional and research financial footprint of $89 as recorded in the federal CMS Open Payments database.

$89 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABU MALOUH's primary funding source is SHIONOGI, which accounts for $28 (representing 31% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

SHIONOGI

Rank 1

$28

31%

MAYNE PHARMA

Rank 2

$18

20.3%

THERATECHNOLOGIES

Rank 3

$17

19.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.